학술논문
O-015 Association between depth of response (DpR) and survival outcomes in RAS-wild-type (wt) patients with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab once-every-2-weeks in the APEC study
Document Type
Article
Author
Source
In Annals of Oncology June 2016 27 Supplement 2:ii123-ii123
Subject
Language
ISSN
0923-7534